APLIF - Appili Therapeutics GAAP EPS of -C$0.38
- Appili Therapeutics press release ( OTCQX:APLIF ): FY GAAP EPS of -C$0.38.
- At March 31, 2022, the Company had cash and short-term investments of C$6.7 million compared to C$16.1 million at March 31, 2021.
For further details see:
Appili Therapeutics GAAP EPS of -C$0.38